amylase 39150 UNT / lipase 10440 UNT / protease 39150 UNT Oral Tablet
RxNorm concept 1247386, clinical drug (scd). Prescribable name: lipase 10,400 UNT / amylase 39,150 UNT / protease 39,150 UNT Oral Tablet.
- RxCUI
- 1247386
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1247386 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
amylase 39,150 UNT / lipase 10,440 UNT / protease 39,150 UNT Oral Tablet; amylases 39,150 UNT / endopeptidases 39,150 UNT / lipase 10,440 UNT Oral Tablet
Related concepts
- amylase 39150 UNT (SCDC, consists of)
- protease 39150 UNT (SCDC, consists of)
- lipase 10440 UNT (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- amylase 39150 UNT / lipase 10440 UNT / protease 39150 UNT Oral Tablet [Viokace] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1247386 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1247386 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1247386. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.